Mission Biocapital
Venture Capital Exempt reporting adviser
Legal name: Bioinnovation Management LLC
Cambridge, MA Website
AUM
$210.9M
Private fund assets
Private funds
1
Venture Capital 1
Private fund assets
$210.9M
Gross asset value
Employees
—
Last Form D raise
Feb 2017
Most recent fund filing
From SEC Form ADV filing (filed Mar 26, 2026). View on SEC
People(6)
Owners and executive officers named on the firm's SEC Form ADV.
D
E
Managing General Partner and Director, and Series B Member of Bioinnovation Management LLC
J
General Partner and Director and Series B Member of Bioinnovation Management LLC
P
Managing General Partner, CEO, and Series A and B Member of Bioinnovation Management LLC
S
S
Senior Advisor, Director and Series B Member of Bioinnovation Management LLC
Funds(1)
Private funds reported on Form ADV, with amounts raised from the funds' SEC Form D filings.
| Fund | Type | Gross assets | Raised (Form D) | Investors | Last Form D | Recency |
|---|---|---|---|---|---|---|
| Bioinnovation Capital I LP | Venture Capital | $210.9M | $65.6M | 12 | Feb 2017 | Cold |
Board seats
Companies whose SEC Form D filings name one of this firm's people as a director, matched by name and office ZIP code.
No board seats matched from SEC filings yet.
Regulatory identifiers
- CRD number
- 283710
- SEC file number
- 802-107753
Sources
- SEC Form ADV Oct 14, 2026